Other clinical data for those populations, including stage of BC, medications, presence of other diseases, and status of the estrogen receptor (ER+ and ER–), human epidermal growth factor receptor (positive and negative), and progesterone receptor (positive and negative), were collected and are summarized in Table 1. This evidence concerns the gene PGR and breast cancer.